Your browser doesn't support javascript.
loading
Outcomes and prognostic factors of adults with refractory or relapsed T-cell acute lymphoblastic leukemia included in measurable residual disease-oriented trials.
Ribera, Josep-Maria; Morgades, Mireia; Genescà, Eulàlia; Chapchap, Eduardo-Cerello; Montesinos, Pau; Acuña-Cruz, Evelyn; Gil, Cristina; García-Cadenas, Irene; Barba, Pere; González-Campos, José; Queipo de Llano, María-Paz; Torrent, Anna; Ribera, Jordi; Granada, Isabel; Bernal, Teresa; Díaz-Beyá, Marina; Amigo, María-Luz; Coll, Rosa; Tormo, Mar; Vall-Llovera, Ferran; Gómez-Centurión, Ignacio; Sánchez-Sánchez, María-José; Soria, Beatriz; Cladera, Antonia; Artola, María-Teresa; Garcia-Guiñon, Antoni; Giménez-Conca, Alberto; Amador, María-Lourdes; Martínez-Sánchez, Pilar; Algarra, Jesús-Lorenzo; Vidal, María-Jesús; Alonso, Natalia; Maluquer, Clara; Llorente, Laura; García-Boyero, Raimundo; Ciudad, Juana; Feliu, Evarist; Orfao, Alberto.
Afiliação
  • Ribera JM; Hematology Department, Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Josep Carreras Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Morgades M; Hematology Department, Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Josep Carreras Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Genescà E; Hematology Department, Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Josep Carreras Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Chapchap EC; Hematology Department, Hospital Israelita Albert Einstein, Sao Paulo, Brazil.
  • Montesinos P; Hematology Department, Hospital Universitari i Politènic La Fe, Valencia, Spain.
  • Acuña-Cruz E; Hematology Department, Hospital Universitari i Politènic La Fe, Valencia, Spain.
  • Gil C; Hematology Department, Hospital General de Alicante, Alicante, Spain.
  • García-Cadenas I; Hematology Department, Hospital de Sant Pau, Barcelona, Spain.
  • Barba P; Hematology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • González-Campos J; Hematology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
  • Queipo de Llano MP; Hematology Department, Hospital Universitario Virgen de la Victoria, Málaga, Spain.
  • Torrent A; Hematology Department, Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Josep Carreras Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Ribera J; Hematology Department, Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Josep Carreras Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Granada I; Hematology Department, Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Josep Carreras Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Bernal T; Hematology Department, Hospital Central de Asturias, ISPA, IUOPA, Oviedo, Spain.
  • Díaz-Beyá M; Hematology Department, Hospital Clínic, Barcelona, Spain.
  • Amigo ML; Hematology Department, Hospital Morales Meseguer, Murcia, Spain.
  • Coll R; Hematology Department, Institut Català d'Oncologia, Hospital Josep Trueta, Girona, Spain.
  • Tormo M; Hematology and Oncology Department, Instituto de investigación INCLIVA, Hospital Clínico Universitario, Valencia, Spain.
  • Vall-Llovera F; Hematology Department, Hospital Universitari Mútua de Terrasa, Terrassa, Spain.
  • Gómez-Centurión I; Hematology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • Sánchez-Sánchez MJ; Hematology Department, Hospital Universitario Lucus Augusti, Lugo, Spain.
  • Soria B; Hematology Department, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain.
  • Cladera A; Hematology Department, Hospital Son Llàtzer, Palma de Mallorca, Spain.
  • Artola MT; Hematology Department, Hospital Universitario de Donostia, Donostia, Spain.
  • Garcia-Guiñon A; Hematology Department, Hospital Arnau de Vilanova, Lleida, Spain.
  • Giménez-Conca A; Hematology Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
  • Amador ML; Hematology Department, Complejo Hospitalario de Pontevedra, Spain.
  • Martínez-Sánchez P; Hematology Department, Hospital 12 de Octubre, Madrid, Spain.
  • Algarra JL; Hematology Department, Hospital General Universitario Albacete, Albacete, Spain.
  • Vidal MJ; Hematology Department, Hospital Universitario de León, León, Spain.
  • Alonso N; Hematology Department, Hospital Universitario Santiago de Compostela, Santiago, Spain.
  • Maluquer C; Hematology Department, Institut Catala d'Oncologia-Hospital Duran y Reynals, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Llorente L; Hematology Department, Hospital HM Sanchinarro, Madrid, Spain.
  • García-Boyero R; Hematology Department, Hospital General Universitario de Castellón, Castellón, Spain.
  • Ciudad J; Hematology Department, Centro de Investigación del Cáncer, IBSAL, IBMCC, CIBERONC, Hospital Universitario, Universidad de Salamanca-CSIC, Salamanca, Spain.
  • Feliu E; Hematology Department, Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Josep Carreras Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Orfao A; Hematology Department, Centro de Investigación del Cáncer, IBSAL, IBMCC, CIBERONC, Hospital Universitario, Universidad de Salamanca-CSIC, Salamanca, Spain.
Hematol Oncol ; 39(4): 529-538, 2021 Oct.
Article em En | MEDLINE | ID: mdl-34405901
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células T Precursoras Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Hematol Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células T Precursoras Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Hematol Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha